Advanced (Unresectable or Metastatic) Melanoma Clinical Trials in Ivano-Frankivsk

Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma